Bristol Myers’ Opdivo-Yervoy Combo Meets Main Goal in Liver Cancer Trial

Source link :

(Reuters) -Bristol Myers Squibb said on Wednesday a combination of Opdivo and Yervoy met the main goal of a late-stage study evaluating it as an initial treatment for a type of liver cancer. The results bolster the company’s efforts to expand the use for the blockbuster drugs that are set to lose their market exclusivity […]

Author : News Health

Publish date : 2024-03-20 11:07:33

Copyright for syndicated content belongs to the linked Source.